Literature DB >> 2418046

Sample preparation for the determination of 5-aza-2'-deoxycytidine in plasma by high-performance liquid chromatography.

K T Lin, R L Momparler, G E Rivard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418046     DOI: 10.1016/0378-4347(85)80148-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.

Authors:  Metin Karahoca; Richard L Momparler
Journal:  Clin Epigenetics       Date:  2013-02-01       Impact factor: 6.551

2.  The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.

Authors:  D J Richel; L P Colly; J C Kluin-Nelemans; R Willemze
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

3.  A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

Authors:  Robert J Arceci; Bodour Salhia; Lia Gore; Timothy J Triche; Jason E Farrar; Daniel Wai; Christophe Legendre; Gerald C Gooden; Winnie S Liang; John Carpten; David Lee; Frank Alvaro; Margaret E Macy; Carola Arndt; Philip Barnette; Todd Cooper; Laura Martin; Aru Narendran; Jessica Pollard; Soheil Meshinchi; Jessica Boklan
Journal:  Clin Epigenetics       Date:  2017-10-05       Impact factor: 6.551

4.  LC-MS/MS Analysis on Infusion Bags and Filled Syringes of Decitabine: New Data on Physicochemical Stability of an Unstable Molecule.

Authors:  Mariarita Laforgia; Loredana Amodio; Santina Colangiulo; Valentina Ungaro; Letizia Gatti; Gianpiero Lucarelli; Marcello Leopoldo; Patrizia Nardulli; Nicola A Colabufo
Journal:  ACS Omega       Date:  2022-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.